Drug Testing Locations - Burlington, ND

Drug Testing in Burlington, ND

Burlington, North Dakota Statistics

In Burlington, Ward County, approximately 7% of residents reported illicit drug use in the past year.

Ward County, where Burlington is located, has seen a 15% increase in drug-related arrests over the last three years.

The rate of opioid overdoses in Burlington, ND, is 25% lower compared to the national average.

Burlington police reported over 50 drug seizures within the city limits in 2022.

Methamphetamine use in Ward County, including Burlington, has risen by 10% since 2020.

In Burlington, ND, 20% of high school students admitted to using marijuana in the last year.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Burlington, ND & Drug Testing Policies

Employers in Burlington, ND, are increasingly implementing drug testing policies to maintain a safe and productive workplace environment. These policies often include pre-employment screening and random testing of employees. Local and federal guidelines, such as those from the U.S. Department of Labor, provide guidance on implementing these procedures.

The city encourages cooperative work between businesses and community health organizations to ensure employees have access to necessary support services. Many employers partner with the Substance Abuse and Mental Health Services Administration (SAMHSA) to provide resources and counseling to employees struggling with addiction.

Government Efforts with Drug Problems in Burlington, ND

The government of Burlington, ND, alongside Ward County officials, has been actively working to address drug problems through various initiatives. Numerous community programs have been developed to raise awareness and improve access to addiction treatment services. For more information, visit the North Dakota Department of Human Services.

State-level efforts in North Dakota focus on prevention and treatment initiatives, including making Narcan more accessible to combat opioid overdoses. These actions are supported by collaborations with federal agencies, like the Drug Enforcement Administration, to dismantle drug trafficking operations and reduce drug availability on the streets.

Local Drug Busts & News in Burlington, ND

In recent years, Burlington, ND, has seen several significant drug busts, resulting in the seizure of large quantities of opioids and methamphetamines. These operations often involve collaborations between local law enforcement and federal agencies like the DEA, targeting trafficking networks.

Community events are frequently organized to raise awareness about drug abuse and promote safe use of prescribed medications. Law enforcement agencies in Burlington also host public forums to discuss the impact of drug-related crimes and the importance of community involvement in prevention efforts.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Burlington, ND. Trusted by employers nationwide for accurate results and exceptional service.

North Dakota DOT/Non DOT Physicals

North Dakota Vision Tests

North Dakota Audiograms

North Dakota Respirator Fit Tests

North Dakota Lift Tests

North Dakota Background Checks

Clinical Testing Services

TB Testing in ND

Diabetes Testing in ND

Infectious Disease Testing in ND

Sickle Cell Anemia Testing in ND

Women/Men's Health Testing in ND

Resources & Citations

North Dakota Department of Human Services

Drug Enforcement Administration

Substance Abuse and Mental Health Services Administration

ND Community Mental Health Services

Office of Recovery Reinvented North Dakota

Burleigh Sumadd Programs

Heartview Foundation

Pathways of Bismarck

Drug Testing Near Burlington, ND

Lansford, ND

Tagus, ND

Sawyer, ND

Hartland, ND

Deering, ND

Glenburn, ND

Carpio, ND

Berthold, ND

Surrey, ND

Foxholm, ND

Ruthville, ND

Minot, ND

Des Lacs, ND

Frequently Asked Questions

Customer Reviews